Onset of pyoderma gangrenosum after tocilizumab therapy for Takayasu arteritis: A new undescribed paradoxical reaction

Br J Clin Pharmacol. 2021 Aug;87(8):3378-3379. doi: 10.1111/bcp.14756. Epub 2021 Feb 10.

Authors

Francesco Borgia¹, Diana Sutera², Alessandra Spagnolo², Francesca Mazza², Lucrezia Bertino¹, Serafinella Patrizia Cannavò¹, Romina Gallizzi²

Affiliations

¹ Department of Clinical and Experimental Medicine, Section of Dermatology, University of Messina, Messina, Italy.
² Department of Human Pathology of Adulthood and Childhood Gaetano Barresi, Unit of Pediatrics, University of Messina, Messina, Italy.

PMID: 33567476
DOI: 10.1111/bcp.14756

No abstract available

Keywords: Takayasu arteritis; paradoxical drug reaction; pyoderma gangrenosum; tocilizumab.

Publication types

Letter

MeSH terms

Antibodies, Monoclonal, Humanized / adverse effects
Humans
Pyoderma Gangrenosum* / chemically induced
Pyoderma Gangrenosum* / drug therapy
Takayasu Arteritis* / drug therapy

Substances

Antibodies, Monoclonal, Humanized
tocilizumab